FRMD8 antibodies are utilized in multiple biochemical and cellular assays:
Antibodies conjugated with fluorophores (e.g., Alexa Fluor 350/555) are frequently used for IF .
In vivo-grade antibodies are required for functional interference studies .
FRMD8 stabilizes iRhoms, which are essential for ADAM17 activity. Studies using FRMD8 antibodies have demonstrated:
TNF-α Shedding: FRMD8 depletion reduces TNF-α release, highlighting its role in inflammatory responses .
Wnt Pathway Modulation: FRMD8 negatively regulates Wnt signaling by disrupting AXIN1-LRP6 interactions .
Cancer: FRMD8’s regulation of growth factor shedding (e.g., amphiregulin) implicates it in tumor microenvironments .
Autoimmune Diseases: Dysregulated FRMD8/iRhom interactions may contribute to aberrant cytokine release .
Abcam ab169933: Validated in WB and IHC-P, with specificity confirmed against human FRMD8 .
Bioss Inc. Polyclonal: Broad applicability across WB, ELISA, and IF, though requires optimization for each assay .